ABVC

ABVC BioPharma · USD

Market open US (NYSE / Nasdaq) · 09:30–16:00 · Mon 14:15 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About ABVC BioPharma

ABVC BioPharma (ABVC) is a biopharmaceutical company focused on developing and commercializing innovative therapies for rare diseases, operating within the Healthcare sector.

HealthcareBiotechnologyResearch & DevelopmentInvestments

Ticker	ABVC
Name	ABVC BioPharma
Currency	USD
Sector	Healthcare

Reputation

😎

How liked 50/100

From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

…

good bad neutral closed

Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

BULLISH

65.78

RSI (14)i

1.26

SMA 20i

1.22

SMA 50i

2.03

SMA 200i

0.89%

1di

-5.63%

1wi

29.43%

1mi

4.54%

30d voli

4.74

52w highi

0.91

52w lowi

-71.33%

from highi

0.05

MACDi

Downtrend (50d below 200d)MACD bullish crossover

Computed from 255 locally-stored price bars.

AI signals

HOLD 70% · long_term 2026-06-08 10:01

The stock has experienced a strong positive move over the past week, with significant gains in price and volume. However, there are no recent news or market events to support this trend continuation. The recent close at 1.33 is slightly below the previous day's high of 1.44, suggesting some consolidation might be expected. Given these factors, a cautious approach (HOLD) seems prudent until more information becomes available.

qwen2.5:3b